Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Hepatology International · 2025-02 · 19 (1) · 1-69
DOI: 10.1007/s12072-024-10773-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hepatology International, online erschienen am 17.02.2025. Verfasst von Ashok Choudhury und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110070, India. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 312 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the working party of the Asian Pacific Association for the Study of the Liver (APASL) set in 2004 on ACLF was published in 2009, and the “APASL ACLF Research Consortium (AARC)” was formed in 2012. The AARC database has prospectively collected nearly 10,500 cases of ACLF from various countries in the Asia–Pacific region. This database has been instrumental in developing the AARC score and grade of ACLF, the concept of the ‘Golden Therapeutic Window’, the ‘transplant window’, and plasmapheresis as a treatment modality. Also, the data has been key to identifying pediatric ACLF. The European Association for the Study of Liver-Chronic Liver Failure (EASL CLIF) and the North American Association for the Study of the End Stage Liver Disease (NACSELD) from the West added the concepts of organ failure and infection as precipitants for the development of ACLF and CLIF-Sequential Organ Failure Assessment (SOFA) and NACSELD scores for prognostication. The Chinese Group on the Study of Severe Hepatitis B (COSSH) added COSSH-ACLF criteria to manage hepatitis b virus-ACLF with and without cirrhosis. The literature supports these definitions to be equally effective in their respective cohorts in identifying patients with high mortality. To overcome the differences and to develop a global consensus, APASL took the initiative and invited the global stakeholders, including opinion leaders from Asia, EASL and AASLD, and other researchers in the field of ACLF to identify the key issues and develop an evidence-based consensus document. The consensus document was presented in a hybrid format at the APASL annual meeting in Kyoto in March 2024. The ‘Kyoto APASL Consensus’ presented below carries the final recommendations along with the relevant background information and areas requiring future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110070, India.
- Asian Institute of Gastroenterology Hospitals, Hyderabad, India.
- Medanta-The Medicity Hospital, Gurugram, Haryana, India.
- Ankara University School of Medicine, Ankara, Turkey.
- Institute of Post-Graduate Medical Education and Research (IPGMER), Kolkata, West Bengal, India.
- VPS Lakeshore Hospital and Research Center Ltd, Kochi, Kerala, India.
Zitieren
APA
Choudhury, A., Kulkarni, A. V., Arora, V., Soin, A. S., Dokmeci, A. K., Chowdhury, A., Koshy, A., Duseja, A., Kumar, A., Mishra, A. K., Patwa, A. K., Sood, A., Roy, A., Shukla, A., Chan, A., Krag, A., Mukund, A., Mandot, A., Goel, A., …, & Lesmana, C. R. A. (2025). Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia. Hepatology International, 19(1), 1-69. https://doi.org/10.1007/s12072-024-10773-4
Vancouver
Choudhury A, Kulkarni AV, Arora V, Soin AS, Dokmeci AK, Chowdhury A, et al. Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia. Hepatology International. 2025;19(1):1-69. doi:10.1007/s12072-024-10773-4
BibTeX
@article{Choudhury2025,
author = {Choudhury, Ashok and Kulkarni, Anand V and Arora, Vinod and Soin, A S and Dokmeci, Abdul Kadir and Chowdhury, Abhijeet and Koshy, Abraham and Duseja, Ajay and Kumar, Ajay and Mishra, Ajay Kumar and Patwa, Ajay Kumar and Sood, Ajit and Roy, Akash and Shukla, Akash and Chan, Albert and Krag, Aleksander and Mukund, Amar and Mandot, Ameet and Goel, Amit and Butt, Amna Subhan and Sahney, Amrish and Shrestha, Ananta and Cárdenas, Andrés and Di Giorgio, Angelo and Arora, Anil and Anand, Anil Chandra and Dhawan, Anil and Jindal, Ankur and Saraya, Anoop and Srivastava, Anshu and Kumar, Anupam and Kaewdech, Apichat and Pande, Apurva and Rastogi, Archana and Valsan, Arun and Goel, Ashish and Kumar, Ashish and Singal, Ashwani K and Tanaka, Atsushi and Coilly, Audrey and Singh, Ayaskanta and Meena, Babu Lal and Jagadisan, Barath and Sharma, Barjesh Chander and Lal, Bikrant Bihari and Eapen, C E and Yaghi, Cesar and Kedarisetty, Chandan Kumar and Kim, Chang Wook and Panackel, Charles and Yu, Chen and Kalal, Chetan R and Bihari, Chhagan and Huang, Chien Hao and Vasishtha, Chitranshu and Jansen, Christian and Strassburg, Christian and Lin, Chun Yen and Karvellas, Constantine J and Lesmana, Cosmas Rinaldi Adithya},
title = {Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia},
journal = {Hepatology International},
year = {2025},
volume = {19},
number = {1},
pages = {1--69},
doi = {10.1007/s12072-024-10773-4}
}
EUVIMED